PA
FLGT icon

Parallel Advisors’s Fulgent Genetics FLGT Stock Holding History

Parallel Advisors’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.14K Sell
153
-287
-65% -$4.87K ﹤0.01% 3388
2026
Q1 		$7K Sell
440
-800
-65% -$17.4K ﹤0.01% 2907
2025
Q4 		$32.6K Buy
1,240
+90
+8% +$2.33K ﹤0.01% 2066
2025
Q3 		$26K Buy
1,150
+32
+3% +$659 ﹤0.01% 2122
2025
Q2 		$22.2K Buy
1,118
+162
+17% +$3.16K ﹤0.01% 2144
2025
Q1 		$16.2K Buy
956
+654
+217% +$11.1K ﹤0.01% 2243
2024
Q4 		$5.58K Buy
302
+177
+142% +$3.46K ﹤0.01% 2598
2024
Q3 		$2.72K Hold
125
– – ﹤0.01% 2798
2024
Q2 		$2.45K Sell
125
-68
-35% -$1.42K ﹤0.01% 2752
2024
Q1 		$4.19K Buy
193
+46
+31% +$1.14K ﹤0.01% 2585
2023
Q4 		$4.25K Buy
147
+26
+21% +$696 ﹤0.01% 2574
2023
Q3 		$3.24K Sell
121
-109
-47% -$3.72K ﹤0.01% 2660
2023
Q2 		$8.52K Sell
230
-1
-0.4% -$35 ﹤0.01% 2240
2023
Q1 		$7.21K Buy
231
+6
+3% +$193 ﹤0.01% 2271
2022
Q4 		$6.7K Sell
225
-8
-3% -$286 ﹤0.01% 2198
2022
Q3 		$9K Sell
233
-19
-8% -$953 ﹤0.01% 2034
2022
Q2 		$14K Sell
252
-70
-22% -$3.85K ﹤0.01% 1835
2022
Q1 		$20K Sell
322
-339
-51% -$22.3K ﹤0.01% 1714
2021
Q4 		$66K Sell
661
-112
-14% -$9.84K ﹤0.01% 1182
2021
Q3 		$70K Sell
773
-100
-11% -$9.09K ﹤0.01% 1131
2021
Q2 		$81K Sell
873
-391
-31% -$31.2K ﹤0.01% 1023
2021
Q1 		$122K Buy
+1,264
New +$130K 0.01% 806

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Parallel Advisors's FLGT Position: Q2 2026 in Review

Parallel Advisors reduced its Fulgent Genetics (FLGT) stake by 65% in Q2 2026, selling an estimated $4.87K and leaving 153 shares worth $3.14K. The position accounts for ﹤0.01% of the portfolio, ranked #3388.

Parallel Advisors first reported a position in FLGT in Q1 2021 and has held it in 22 quarters since. The position peaked at $122K in Q1 2021. 142 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Parallel Advisors held 153 shares of Fulgent Genetics worth $3.14K as of Q2 2026.
  • Parallel Advisors sold 287 Fulgent Genetics shares in Q2 2026, an estimated $4.87K.
  • Fulgent Genetics made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #3388 holding.
  • Parallel Advisors first reported a position in Fulgent Genetics in Q1 2021 and has held it in 22 quarters since.
  • Parallel Advisors's Fulgent Genetics position peaked at $122K in Q1 2021.
  • 142 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.